Dr. Jayaram Srinivasan Brindala, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Medicare Enrolled Practice Location: 755 Rinehart Rd Ste 200, Lake Mary, FL 32746 Phone: 407-320-8100 Fax: 407-320-8110 |
Dr. Gordon Johnson Crozier, DO Preventive Medicine - Public Health & General Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1307 S International Pkwy, Suite 2071, Lake Mary, FL 32746 Phone: 606-776-7707 Fax: 407-732-7669 |
Linda Gail King, D.O. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Medicare Enrolled Practice Location: 1349 S International Pkwy, Suite 1431, Lake Mary, FL 32746 Phone: 407-333-3372 Fax: 407-333-3672 |
News Archive
In Parkinson's disease, the protein "alpha-synuclein" aggregates within neurons of patients and appears to propagate across interconnected areas of the brain. How this happens remains largely unknown.
SYSPRO, the leading provider of visionary, pragmatic ERP software, today announced a strategic partnership with Avalara, a leading provider of fully automated, up-to-date sales and use tax compliance solutions. SYSPRO will now offer AvaTax for SYSPRO, a solution that leverages off the open SYSPRO technology architecture to deliver a totally integrated service that speeds up and simplifies the exacting taxation requirements of SMB manufacturers and distributors.
Up to 10 percent of women newly diagnosed with cancer in one breast develop cancer in the opposite breast.
Embargoed Until January 18, 2009 at 18:00 Greenwich Mean Time / 13:00 Eastern Standard Time (TORONTO): Scientists at the Centre for Addiction and Mental Health (CAMH) have detected evidence that DNA may not be the only carrier of heritable information; a secondary molecular mechanism called epigenetics may also account for some inherited traits and diseases.
ZIOPHARM Oncology, a small molecule late-stage oncology drug development company, and Intrexon Corporation, a next generation synthetic biology company, announced today a global exclusive channel partnership in oncology where ZIOPHARM will develop and commercialize DNA-based therapeutics using Intrexon's UltraVector Technology.
› Verified 2 days ago